Clinical Trial Update: A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atezolizumab to docetaxel in locally advanced or metastatic non-squamous non-small cell lung cancer after platinum therapy has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Squamous Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-07-02